Skip to main content
Erschienen in: Journal of Clinical Immunology 1/2016

01.01.2016 | Original Article

Molecular Characteristics, Clinical and Immunologic Manifestations of 11 Children with Omenn Syndrome in East Slavs (Russia, Belarus, Ukraine)

verfasst von: Svetlana O. Sharapova, Irina E. Guryanova, Olga E. Pashchenko, Irina V. Kondratenko, Larisa V. Kostyuchenko, Yulia A. Rodina, Tatjana V. Varlamova, Anastasiia V. Bondarenko, Liudmyla I. Chernyshova, Marina N. Gyseva, Mikhail V. Belevtsev, Nina V. Minakovskaya, Olga V. Aleinikova

Erschienen in: Journal of Clinical Immunology | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

Omenn syndrome [Mendelian Inheritance (OMIM 603554)] is a genetic disease of the immune system, characterized by the presence of fatal generalized severe erythroderma, lymphoadenopathy, eosinophilia and profound immunodeficiency.

Objective

We studied clinical and immunologic presentation of the disease manifestation among East Slavs population with genetically confirmed Omenn syndrome.

Results

We collected clinical and immunologic data of 11 patients (1 from Belarus, 5 – Ukraine, 5 – Russia): 6 females, 5 males. The age of Omenn syndrome manifestation varied from the 1st day of life to 1 year and 1 month, the age of diagnosis – 20 days to 1 year and 10 months. Nine out of 11 patients had classic immunologic phenotype T(+/−)B-NK+, 1 pt had TlowB + NK+ with CD3 + TCRgd + expansion and 1 had TlowB+/−NK+ phenotype. Eight out of 11 pts had mutation in RAG1 gene, 4 out of 8 had c.368-369delAA (p.K86fsX118) in homozygous state or heterozygous compound. In our cohort of patients, we also described two new mutations in RAG genes (p.E722Q in RAG1 and p.M459R in RAG2). At present, 7/11 were transplanted and 5 out of the transplanted are alive.

Conclusion

This study demonstrates that the most popular genetic abnormality in East Slavs children with Omenn syndrome is c.368-369delAA (p.K86fs118) in RAG1 gene, which may be connected with more favorable prognosis because 4/4 patients survived after hematopoietic stem cells transplantation.
Literatur
1.
Zurück zum Zitat Hönig M, Schwarz K. Omenn syndrome: a lack of tolerance on the background of deficient lymphocyte development and maturation. Curr Opin Rheumatol. 2006;18(4):383–8.PubMedCrossRef Hönig M, Schwarz K. Omenn syndrome: a lack of tolerance on the background of deficient lymphocyte development and maturation. Curr Opin Rheumatol. 2006;18(4):383–8.PubMedCrossRef
2.
3.
Zurück zum Zitat Villa A, Notarangelo LD, Roifman CM. Omenn syndrome: inflammation in leaky severe combined immunodeficiency. J Allergy Clin Immunol. 2008;122(6):1082–6.PubMedCrossRef Villa A, Notarangelo LD, Roifman CM. Omenn syndrome: inflammation in leaky severe combined immunodeficiency. J Allergy Clin Immunol. 2008;122(6):1082–6.PubMedCrossRef
4.
Zurück zum Zitat Santagata S, Villa A, Sobacchi C, Cortes P, Vezzoni P. The genetic and biochemical basis of omenn syndrome. Immunol Rev. 2000;178:64–74.PubMedCrossRef Santagata S, Villa A, Sobacchi C, Cortes P, Vezzoni P. The genetic and biochemical basis of omenn syndrome. Immunol Rev. 2000;178:64–74.PubMedCrossRef
5.
Zurück zum Zitat Chilosi M, Facchetti F, Notarangelo LD, Romagnani S, Del Prete G, Almerigogna F, De Carli M. The pathology of omenn’s syndrome. Am J Surg Pathol. 1996;20(6):773–4.PubMedCrossRef Chilosi M, Facchetti F, Notarangelo LD, Romagnani S, Del Prete G, Almerigogna F, De Carli M. The pathology of omenn’s syndrome. Am J Surg Pathol. 1996;20(6):773–4.PubMedCrossRef
6.
Zurück zum Zitat Schwarz K, Gauss GH, Ludwig L, Pannicke U, Li Z, Lindner D, et al. RAG mutations in human B cell-negative SCID. Science. 1996;274:97–9.PubMedCrossRef Schwarz K, Gauss GH, Ludwig L, Pannicke U, Li Z, Lindner D, et al. RAG mutations in human B cell-negative SCID. Science. 1996;274:97–9.PubMedCrossRef
7.
Zurück zum Zitat Ege M, Ma Y, Manfras B, Kalwak K, Lu H, Lieber MR, et al. Omenn syndrome due to Artemis mutations. Blood. 2005;105:4179–86.PubMedCrossRef Ege M, Ma Y, Manfras B, Kalwak K, Lu H, Lieber MR, et al. Omenn syndrome due to Artemis mutations. Blood. 2005;105:4179–86.PubMedCrossRef
8.
Zurück zum Zitat Mancebo E, Recio MJ, Martínez-Busto E, González-Granado LI, Rojo P, Fernández-Díaz E, Ruiz Contreras J, Paz-Artal E, Allende LM. Possible role of Artemis c.512C > G polymorphic variant in omenn syndrome. DNA Repair (Amst). 2011;10(1):3–4.CrossRef Mancebo E, Recio MJ, Martínez-Busto E, González-Granado LI, Rojo P, Fernández-Díaz E, Ruiz Contreras J, Paz-Artal E, Allende LM. Possible role of Artemis c.512C > G polymorphic variant in omenn syndrome. DNA Repair (Amst). 2011;10(1):3–4.CrossRef
9.
Zurück zum Zitat Giliani S, Bonfim C, de Saint BG, Lanzi G, Brousse N, Koliski A, et al. Omenn syndrome in an infant with IL7RA gene mutation. J Pediatr. 2006;148:272–4.PubMedCrossRef Giliani S, Bonfim C, de Saint BG, Lanzi G, Brousse N, Koliski A, et al. Omenn syndrome in an infant with IL7RA gene mutation. J Pediatr. 2006;148:272–4.PubMedCrossRef
10.
Zurück zum Zitat Roifman CM, Zhang J, Atkinson A, Grunebaum E, Mandel K. Adenosine deaminase deficiency can present with features of omenn syndrome. J Allergy Clin Immunol. 2008;121:1056–8.PubMedCrossRef Roifman CM, Zhang J, Atkinson A, Grunebaum E, Mandel K. Adenosine deaminase deficiency can present with features of omenn syndrome. J Allergy Clin Immunol. 2008;121:1056–8.PubMedCrossRef
11.
Zurück zum Zitat Shibata F, Toma T, Wada T, Inoue M, Tone Y, Ohta K, et al. Skin infiltration of CD56(bright) CD16(−) natural killer cells in a case of X-SCID with omenn syndrome-like manifestations. Eur J Haematol. 2007;79:81–5.PubMedCrossRef Shibata F, Toma T, Wada T, Inoue M, Tone Y, Ohta K, et al. Skin infiltration of CD56(bright) CD16(−) natural killer cells in a case of X-SCID with omenn syndrome-like manifestations. Eur J Haematol. 2007;79:81–5.PubMedCrossRef
12.
Zurück zum Zitat Grunebaum E, Bates A, Roifman CM. Omenn syndrome is associated with mutations in DNA ligase IV. J Allergy Clin Immunol. 2008;122(6):1219–20.PubMedCrossRef Grunebaum E, Bates A, Roifman CM. Omenn syndrome is associated with mutations in DNA ligase IV. J Allergy Clin Immunol. 2008;122(6):1219–20.PubMedCrossRef
13.
Zurück zum Zitat Gennery AR, Slatter MA, Rice J, Hoefsloot LH, Barge D, McLean-Tooke A, Montgomery T, Goodship JA, Burt AD, Flood TJ, Abinun M, Cant AJ, Johnson D. Mutations in CHD7 in patients with CHARGE syndrome cause T-B+ natural killer cell + severe combinedimmune deficiency and may cause omenn-like syndrome. Clin Exp Immunol. 2008;153(1):75–80.PubMedPubMedCentralCrossRef Gennery AR, Slatter MA, Rice J, Hoefsloot LH, Barge D, McLean-Tooke A, Montgomery T, Goodship JA, Burt AD, Flood TJ, Abinun M, Cant AJ, Johnson D. Mutations in CHD7 in patients with CHARGE syndrome cause T-B+ natural killer cell + severe combinedimmune deficiency and may cause omenn-like syndrome. Clin Exp Immunol. 2008;153(1):75–80.PubMedPubMedCentralCrossRef
15.
Zurück zum Zitat Kostyuchenko L, Makuch H, Kitsera N, Polishchuk R, Markevych N, Akopian H. Nijmegen breakage syndrome in Ukraine: diagnostics and follow-up. Centr Eur J Immunol. 2009;34(1):46–52. Kostyuchenko L, Makuch H, Kitsera N, Polishchuk R, Markevych N, Akopian H. Nijmegen breakage syndrome in Ukraine: diagnostics and follow-up. Centr Eur J Immunol. 2009;34(1):46–52.
16.
Zurück zum Zitat Kondratenko IV, Bologov AA, Rodina YA, Pashchenko OE, Belevtsev MV. Severe combined immunodeficiency caused by mutations in genes RAG1/RAG2 (literature review and clinical examples). Allergol Immunol Pediatr 2012; 3:13–20. [Article in Russian]. Kondratenko IV, Bologov AA, Rodina YA, Pashchenko OE, Belevtsev MV. Severe combined immunodeficiency caused by mutations in genes RAG1/RAG2 (literature review and clinical examples). Allergol Immunol Pediatr 2012; 3:13–20. [Article in Russian].
17.
Zurück zum Zitat Sharapova SO, Migas AA, Guryanova IE, Aleshkevich SN, Pashchenko OE, Kondratenko IV, Belevtsev MV, Aleinikova OV. Immune dysregulation in patients with different types of severe combined immune deficiencies. Proc Natl Acad Sci Belarus (Medicine series), 2013; 4:87–97. [Article in Russian]. Sharapova SO, Migas AA, Guryanova IE, Aleshkevich SN, Pashchenko OE, Kondratenko IV, Belevtsev MV, Aleinikova OV. Immune dysregulation in patients with different types of severe combined immune deficiencies. Proc Natl Acad Sci Belarus (Medicine series), 2013; 4:87–97. [Article in Russian].
18.
Zurück zum Zitat Chernyshova LI, Bondarenko AV, Starenkaya SYa. Manifestation of primary immunodeficiency in the neonatal period. Mod Pediatr. 2013; 6:150–152. [Article in Russian]. Chernyshova LI, Bondarenko AV, Starenkaya SYa. Manifestation of primary immunodeficiency in the neonatal period. Mod Pediatr. 2013; 6:150–152. [Article in Russian].
19.
Zurück zum Zitat IJspeert H, Driessen GJ, Moorhouse MJ, Hartwig NG, Wolska-Kusnierz B, Kalwak K, et al. Similar recombination-activating gene (RAG) mutations result in similar immunobiological effects but in different clinical phenotypes. J Allergy Clin Immunol. 2014;133(4):1124–33. IJspeert H, Driessen GJ, Moorhouse MJ, Hartwig NG, Wolska-Kusnierz B, Kalwak K, et al. Similar recombination-activating gene (RAG) mutations result in similar immunobiological effects but in different clinical phenotypes. J Allergy Clin Immunol. 2014;133(4):1124–33.
20.
Zurück zum Zitat de Villartay JP, Lim A, Al-Mousa H, Dupont S, Dechanet-Merville J, Coumau-Gatbois E, et al. A novel immunodeficiency associated with hypomorphic RAG1 mutations and CMV infection. J Clin Invest. 2005;115:3291–9.PubMedPubMedCentralCrossRef de Villartay JP, Lim A, Al-Mousa H, Dupont S, Dechanet-Merville J, Coumau-Gatbois E, et al. A novel immunodeficiency associated with hypomorphic RAG1 mutations and CMV infection. J Clin Invest. 2005;115:3291–9.PubMedPubMedCentralCrossRef
21.
Zurück zum Zitat Ehl S, Schwarz K, Enders A, Duffner U, Pannicke U, Kühr J, Mascart F, et al. A variant of SCID with specific immune responses and predominance of γδ T lymphocytes. J Clin Invest. 2005;115:3240–8.CrossRef Ehl S, Schwarz K, Enders A, Duffner U, Pannicke U, Kühr J, Mascart F, et al. A variant of SCID with specific immune responses and predominance of γδ T lymphocytes. J Clin Invest. 2005;115:3240–8.CrossRef
22.
Zurück zum Zitat Schutz C, Niehues T, Ehl S, Friedrich W, Schwarz K. Autoimmunity, autoinflammation and lymphoma in combined immunodeficiency (CID). Autoimmun Rev. 2010;9:477–82.CrossRef Schutz C, Niehues T, Ehl S, Friedrich W, Schwarz K. Autoimmunity, autoinflammation and lymphoma in combined immunodeficiency (CID). Autoimmun Rev. 2010;9:477–82.CrossRef
23.
Zurück zum Zitat Villa A, Sobacchi C, Notarangelo LD, Bozzi F, Abinun M, Abrahamsen TG, et al. V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations. Blood. 2001;97:81–8.PubMedCrossRef Villa A, Sobacchi C, Notarangelo LD, Bozzi F, Abinun M, Abrahamsen TG, et al. V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations. Blood. 2001;97:81–8.PubMedCrossRef
24.
Zurück zum Zitat Lee YN, Frugoni F, Dobbs K, Walter JE, Giliani S, Gennery AR, Al-Herz W, Haddad E, et al. A systematic analysis of recombination activity and genotype-phenotype correlation in human recombination-activating gene 1 deficiency. J Allergy Clin Immunol. 2014;133(4):1099–108.PubMedPubMedCentralCrossRef Lee YN, Frugoni F, Dobbs K, Walter JE, Giliani S, Gennery AR, Al-Herz W, Haddad E, et al. A systematic analysis of recombination activity and genotype-phenotype correlation in human recombination-activating gene 1 deficiency. J Allergy Clin Immunol. 2014;133(4):1099–108.PubMedPubMedCentralCrossRef
25.
Zurück zum Zitat Sharapova SO, Migas A, Guryanova I, Aleshkevich S, Kletski S, Durandy A, Belevtsev M. Late-onset combined immune deficiency associated to skin granuloma due to heterozygous compound mutations in RAG1 gene in a 14 years old male. Hum Immunol. 2013;74(1):18–22.PubMedCrossRef Sharapova SO, Migas A, Guryanova I, Aleshkevich S, Kletski S, Durandy A, Belevtsev M. Late-onset combined immune deficiency associated to skin granuloma due to heterozygous compound mutations in RAG1 gene in a 14 years old male. Hum Immunol. 2013;74(1):18–22.PubMedCrossRef
26.
Zurück zum Zitat Felgentreff K, Perez-Becker R, Speckmann C, Schwarz K, Kalwak K, Markelj G, et al. Clinical and immunological manifestations of patients with atypicalsevere combined immunodeficiency. Clin Immunol. 2011;141(1):73–82.PubMedCrossRef Felgentreff K, Perez-Becker R, Speckmann C, Schwarz K, Kalwak K, Markelj G, et al. Clinical and immunological manifestations of patients with atypicalsevere combined immunodeficiency. Clin Immunol. 2011;141(1):73–82.PubMedCrossRef
27.
Zurück zum Zitat Marciano BE, Huang CY, Joshi G, Rezaei N, Carvalho BC, Allwood Z, Ikinciogullari A, et al. BCG vaccination in patients with severe combined immunodeficiency: complications, risks, and vaccination policies. J Allergy Clin Immunol. 2014;133(4):1134–41.PubMedPubMedCentralCrossRef Marciano BE, Huang CY, Joshi G, Rezaei N, Carvalho BC, Allwood Z, Ikinciogullari A, et al. BCG vaccination in patients with severe combined immunodeficiency: complications, risks, and vaccination policies. J Allergy Clin Immunol. 2014;133(4):1134–41.PubMedPubMedCentralCrossRef
28.
Zurück zum Zitat Bodemer C, Sauvage V, Mahlaoui N, Cheval J, Couderc T, Leclerc-Mercier S, et al. Live rubella virus vaccine long-term persistence as an antigenic trigger of cutaneous granulomas in patients with primary immunodeficiency. Clin Microbiol Infect. 2014;20(10):O656–63.PubMedCrossRef Bodemer C, Sauvage V, Mahlaoui N, Cheval J, Couderc T, Leclerc-Mercier S, et al. Live rubella virus vaccine long-term persistence as an antigenic trigger of cutaneous granulomas in patients with primary immunodeficiency. Clin Microbiol Infect. 2014;20(10):O656–63.PubMedCrossRef
29.
Zurück zum Zitat Pasic S, Vujic D, Veljković D, Slavkovic B, Mostarica-Stojkovic M, Minic P, et al. Severe combined immunodeficiency in Serbia and Montenegro between years 1986 and 2010: a single-center experience. J Clin Immunol. 2014;34(3):304–8.PubMedCrossRef Pasic S, Vujic D, Veljković D, Slavkovic B, Mostarica-Stojkovic M, Minic P, et al. Severe combined immunodeficiency in Serbia and Montenegro between years 1986 and 2010: a single-center experience. J Clin Immunol. 2014;34(3):304–8.PubMedCrossRef
30.
Zurück zum Zitat Pasic S, Djuricic S, Ristic G, Slavkovic B. Recombinase activating gene 1 immunodeficiency: different immunologicalphenotypes in three siblings. Acta Paediatr. 2009;98(6):1062–4.PubMedCrossRef Pasic S, Djuricic S, Ristic G, Slavkovic B. Recombinase activating gene 1 immunodeficiency: different immunologicalphenotypes in three siblings. Acta Paediatr. 2009;98(6):1062–4.PubMedCrossRef
31.
Zurück zum Zitat Safaei S, Pourpak Z, Moin M, Houshmand M. IL7R and RAG1/2 genes mutations/polymorphisms in patients with SCID. Iran J Allergy Asthma Immunol. 2011;10(2):129–32.PubMed Safaei S, Pourpak Z, Moin M, Houshmand M. IL7R and RAG1/2 genes mutations/polymorphisms in patients with SCID. Iran J Allergy Asthma Immunol. 2011;10(2):129–32.PubMed
32.
Zurück zum Zitat Dalal I, Tasher D, Somech R, Etzioni A, Garti BZ, Lev D, Cohen S, Somekh E, Leshinsky-Silver E. Novel mutations in RAG1/2 and ADA genes in Israeli patients presenting with T-B-SCID or omenn syndrome. Clin Immunol. 2011;140(3):284–90.PubMedCrossRef Dalal I, Tasher D, Somech R, Etzioni A, Garti BZ, Lev D, Cohen S, Somekh E, Leshinsky-Silver E. Novel mutations in RAG1/2 and ADA genes in Israeli patients presenting with T-B-SCID or omenn syndrome. Clin Immunol. 2011;140(3):284–90.PubMedCrossRef
33.
Zurück zum Zitat Lee PP, Chan KW, Chen TX, Jiang LP, Wang XC, Zeng HS, et al. Molecular diagnosis of severe combined immunodeficiencyidentification of IL2RG, JAK3, IL7R, DCLRE1C, RAG1, and RAG2 mutations in a cohort of Chinese and Southeast Asian children. J Clin Immunol. 2011;31(2):281–96.PubMedCrossRef Lee PP, Chan KW, Chen TX, Jiang LP, Wang XC, Zeng HS, et al. Molecular diagnosis of severe combined immunodeficiencyidentification of IL2RG, JAK3, IL7R, DCLRE1C, RAG1, and RAG2 mutations in a cohort of Chinese and Southeast Asian children. J Clin Immunol. 2011;31(2):281–96.PubMedCrossRef
34.
Zurück zum Zitat Zhang ZY, Zhao XD, Jiang LP, Liu EM, Cui YX, Wang M, et al. Clinical characteristics and molecular analysis of three Chinese children with omenn syndrome. Pediatr Allergy Immunol. 2011;22(5):482–7.PubMedCrossRef Zhang ZY, Zhao XD, Jiang LP, Liu EM, Cui YX, Wang M, et al. Clinical characteristics and molecular analysis of three Chinese children with omenn syndrome. Pediatr Allergy Immunol. 2011;22(5):482–7.PubMedCrossRef
35.
Zurück zum Zitat Kato M, Kimura H, Seki M, Shimada A, Hayashi Y. Morio Tet al. Omenn syndrome–review of several phenotypes of Omenn syndrome and RAG1/RAG2 mutations in Japan. Allergol Int. 2006;55(2):115–9.PubMedCrossRef Kato M, Kimura H, Seki M, Shimada A, Hayashi Y. Morio Tet al. Omenn syndrome–review of several phenotypes of Omenn syndrome and RAG1/RAG2 mutations in Japan. Allergol Int. 2006;55(2):115–9.PubMedCrossRef
36.
Zurück zum Zitat Abraham RS, Recher M, Giliani S, Walter JE, Lee YN, Frugoni F, et al. Adult-onset manifestation of idiopathic T-cell lymphopenia due to a heterozygous RAG1 mutation. J Allergy Clin Immunol. 2013;131(5):1421–3.PubMedPubMedCentralCrossRef Abraham RS, Recher M, Giliani S, Walter JE, Lee YN, Frugoni F, et al. Adult-onset manifestation of idiopathic T-cell lymphopenia due to a heterozygous RAG1 mutation. J Allergy Clin Immunol. 2013;131(5):1421–3.PubMedPubMedCentralCrossRef
Metadaten
Titel
Molecular Characteristics, Clinical and Immunologic Manifestations of 11 Children with Omenn Syndrome in East Slavs (Russia, Belarus, Ukraine)
verfasst von
Svetlana O. Sharapova
Irina E. Guryanova
Olga E. Pashchenko
Irina V. Kondratenko
Larisa V. Kostyuchenko
Yulia A. Rodina
Tatjana V. Varlamova
Anastasiia V. Bondarenko
Liudmyla I. Chernyshova
Marina N. Gyseva
Mikhail V. Belevtsev
Nina V. Minakovskaya
Olga V. Aleinikova
Publikationsdatum
01.01.2016
Verlag
Springer US
Erschienen in
Journal of Clinical Immunology / Ausgabe 1/2016
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-015-0216-7

Weitere Artikel der Ausgabe 1/2016

Journal of Clinical Immunology 1/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.